tiprankstipranks
Advertisement
Advertisement
Actithera Showcases Covalent FAP-Targeting Strategy at PEGS Summit
PremiumPrivate CompaniesActithera Showcases Covalent FAP-Targeting Strategy at PEGS Summit
16d ago
Actithera – Weekly Recap
Premium
Private Companies
Actithera – Weekly Recap
21d ago
Actithera Emphasizes Long-Term Focus on Targeted Radioligand Oncology Therapies
Premium
Private Companies
Actithera Emphasizes Long-Term Focus on Targeted Radioligand Oncology Therapies
22d ago
Actithera Highlights Participation in ESRR 2026 Radiopharmaceutical Meeting
PremiumPrivate CompaniesActithera Highlights Participation in ESRR 2026 Radiopharmaceutical Meeting
1M ago
Actithera Strengthens Radioligand Therapy R&D Leadership With Senior Hire
Premium
Private Companies
Actithera Strengthens Radioligand Therapy R&D Leadership With Senior Hire
2M ago
Actithera Strengthens RLT Leadership With New Discovery and Preclinical Director
Premium
Private Companies
Actithera Strengthens RLT Leadership With New Discovery and Preclinical Director
2M ago
Actithera Strengthens Strategic Leadership With Radioligand Therapy Expert
PremiumPrivate CompaniesActithera Strengthens Strategic Leadership With Radioligand Therapy Expert
3M ago
Actithera Strengthens Leadership With Strategic Hire in Radioligand Therapy
Premium
Private Companies
Actithera Strengthens Leadership With Strategic Hire in Radioligand Therapy
3M ago
Actithera Strengthens Strategic Leadership With New Chief of Staff and Head of Strategy
Premium
Private Companies
Actithera Strengthens Strategic Leadership With New Chief of Staff and Head of Strategy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100